Convexity Labs

OTIS

Convexity Analyst · OTIS
Holdmedium confidenceTactical · no named thesis
Generated Jun 21, 2026

Analyst Note: Otis Worldwide Corporation (OTIS)

Date: 2026-06-13 Current Price: $73.27

1. Structural Readiness

  • State: Context-only
  • Conservative Entry:
  • Extension:
  • Breakout Level:
  • ATR at Breakout:
  • Current ATR: 2.1% (Sub-threshold)
  • Pivot Strength:
  • Cap Bucket: Large
  • Sector: Technology
  • Industry:

Setup Classification:

2. Thesis Layer

This is a TACTICAL, setup-led name with NO named macro thesis at this date. The analysis must be driven strictly by the quality of the setup structure (which is currently absent) and the underlying business fundamentals. There is no secular theme or macro narrative assigned to this specific setup window; the conviction must be derived solely from the operational data and the eventual formation of a technical structure.

3. Business Overview

Otis Worldwide Corporation is the world's leading manufacturer, installer, and servicer of elevators and escalators. The company operates through two primary segments: New Equipment and Service.

  • New Equipment: This segment designs, manufactures, and installs passenger and freight elevators, escalators, and moving walkways for residential, commercial, retail, and infrastructure projects. Customers include real estate developers and general contractors. As of the latest reporting, the company has secured significant wins, such as the supply of 46 units (including SkyRise and Gen 3 elevators) for the Austin Convention Center redevelopment.
  • Service: This segment provides maintenance, repair, and modernization services. The company maintains a massive installed base of approximately 2.5 million units globally, with a specific focus on converting new installations into long-term service contracts. As of December 31, 2025, approximately 1.1 million units in the global portfolio were connected, supporting the "Otis ONE" connected solution strategy.

Operational Performance (as of April 2026):

  • Backlog: Total backlog remains at historically high levels, approaching $20 billion. The combined new equipment and modernization backlog increased 9% year-over-year.
  • Modernization Demand: Orders in modernization were up 11% in the quarter, with the backlog up 30% at constant currency. Management notes the global outlook for modernization remains robust, growing double digits on a dollar basis due to aging installed base demographics.
  • Sales Growth: Total organic sales increased 1% in the quarter, driven by a 5% increase in organic service growth. However, this was partially offset by a 5% organic sales decrease in the prior period (likely referencing a specific segment or regional comparison in the filing), driven by a greater than 20% decline in China and mid-single-digit declines in Asia Pacific.
  • Guidance: Management expects net sales of $15.1 billion to $15.3 billion for the full year, with organic sales growth in the low to mid-single digits. Adjusted operating profit is expected to grow by $20 million to $60 million on a constant currency basis.
  • Transformation: The "UpLift transformation" has generated run-rate savings of approximately $200 million, with total restructuring costs to complete the transformation at approximately $300 million as of December 31, 2025.

4. Archetype and Conviction

  • Archetype: Quality Compounder.
  • Fit: The company exhibits the characteristics of a quality compounder through its massive, recurring service revenue base (2.5 million units), high backlog visibility ($20 billion), and consistent margin expansion via the UpLift transformation ($200M run-rate savings). The business model relies on the "toll booth" nature of the installed base, where modernization and service provide defensive cash flows even as new equipment cycles fluctuate.
  • Valuation Context: The financial spine indicates a forward consensus EPS of $4.18 for FY1 and $4.70 for FY2.
  • Conviction Stack:
  • Thesis Strength: Low (No named macro thesis; purely tactical).
  • Evidence Quality: High. The evidence block is robust, citing specific backlog figures, order growth rates, and transformation savings from primary earnings transcripts and SEC filings.
  • Structural Quality: Neutral. The business fundamentals are strong, but the technical setup is currently non-existent (context-only).
  • Setup Readiness: None. No coil is forming or confirmed.
  • Rerating Potential: Dependent on the successful execution of the UpLift transformation and the recovery of the New Equipment segment in China, which is currently a drag on organic sales.

5. Invalidations, Strengths, and Gaps

  • What Would Strengthen the Case:
  • Further acceleration in New Equipment orders, specifically a reversal of the >20% decline in China.
  • Expansion of the modernization backlog beyond the current 30% constant currency growth.
  • What Would Invalidate the Case:
  • A sustained decline in the total backlog below $18 billion, threatening future earnings visibility.
  • Failure to realize the projected $200M in run-rate savings from the UpLift transformation.
  • Gaps in Evidence:
  • Regional Specifics: While the China decline is noted, there is no granular data on the timing of the recovery or specific regional guidance beyond the aggregate organic sales figures.
  • Margin Trajectory: While operating profit growth is guided, the specific margin expansion rate post-transformation is not detailed in the provided snippets beyond the savings figure.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: medium Key evidence: Backlog at $20B with 9% YoY growth; Modernization backlog up 30% at constant currency; $200M run-rate savings from UpLift transformation. Key risks: >20% decline in China dragging organic sales; No active technical setup (context-only); Sub-threshold ATR (2.1%) indicating low volatility momentum. Expected path: Management expects low-to-mid single digit organic sales growth and $20M-$60M operating profit growth; structural recovery depends on China stabilization and modernization tailwinds. Expected horizon: 12-18 months for the transformation savings to fully reflect in earnings and for the China cycle to normalize. Failure mode to watch: A sustained drop in total backlog below $18 billion or a failure to achieve the $200M savings target.

Loading chart...
Exhibit 1: OTIS daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for OTIS.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for OTIS.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: